Department of Oral and Maxillofacial-Head and Neck Oncology, Beijing Stomatological Hospital, Capital Medical University, Beijing, China.
Cell Death Dis. 2024 May 29;15(5):376. doi: 10.1038/s41419-024-06759-7.
The tumor margin as the invasive front has been proven to be closely related to the progression and metastasis of oral squamous cell carcinoma (OSCC). However, how tumor cells in the marginal region obtain the extra energy needed for tumor progression is still unknown. Here, we used spatial metabolomics and the spatial transcriptome to identify enhanced energy metabolism in the tumor margin of OSCC and identified that the downregulation of Ras-related glycolysis inhibitor and calcium channel regulator (RRAD) in tumor cells mediated this process. The absence of RRAD enhanced the ingestion of glucose and malignant behaviors of tumor cells both in vivo and in vitro. Mechanically, the downregulation of RRAD promoted the internal flow of Ca and elevated its concentration in the nucleus, which resulted in the activation of the CAMKIV-CREB1 axis to induce the transcription of the glucose transporter GLUT3. GLUT inhibitor-1, as an inhibitor of GLUT3, could suppress this vigorous energy metabolism and malignant behaviors caused by the downregulation of RRAD. Taken together, our study revealed that enhanced energy metabolism in the tumor margin mediated by RRAD promotes the progression of OSCC and proved that GLUT3 is a potential target for future treatment of OSCC.
肿瘤边缘作为侵袭前沿已被证明与口腔鳞状细胞癌 (OSCC) 的进展和转移密切相关。然而,肿瘤边缘区域的肿瘤细胞如何获得肿瘤进展所需的额外能量尚不清楚。在这里,我们使用空间代谢组学和空间转录组学来鉴定 OSCC 肿瘤边缘的增强能量代谢,并鉴定出肿瘤细胞中 Ras 相关糖酵解抑制剂和钙通道调节剂 (RRAD) 的下调介导了这一过程。RRAD 的缺失增强了肿瘤细胞在体内和体外对葡萄糖的摄取和恶性行为。在机制上,RRAD 的下调促进了 Ca 的内流,并增加了其在核内的浓度,从而导致 CAMKIV-CREB1 轴的激活,诱导葡萄糖转运蛋白 GLUT3 的转录。GLUT 抑制剂-1 作为 GLUT3 的抑制剂,可抑制 RRAD 下调引起的这种旺盛的能量代谢和恶性行为。总之,我们的研究揭示了 RRAD 介导的肿瘤边缘增强的能量代谢促进了 OSCC 的进展,并证明 GLUT3 是未来治疗 OSCC 的潜在靶点。